The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.

Eur Neuropsychopharmacol

AP-HP, Hôpital Louis Mourier (Paris VII), service de psychiatrie, 178 rue des Renouillers, 92700 Colombes, France.

Published: January 2008

Neurobiological research suggests a significant role of the endocannabinoid system in schizophrenia vulnerability and also in the quality of response to antipsychotics. Genetics offer an opportunity to disentangle its involvement in the disease vulnerability vs an influence on antipsychotics' effects. The possible role of a tag SNP (the 1359G/A polymorphism) of the gene encoding the cannabinoid receptor type 1 (CNR1) in schizophrenia and/or therapeutic response to atypical antipsychotics was assessed in a cohort of 133 French schizophrenic patients compared to 141 normal control subjects. No difference in 1359G/A polymorphism was observed between patients and control subjects, and no relationships were noted between this polymorphism and any clinical parameter considered as potential intermediate factor. However, the G allele frequency was significantly higher among non-responsive vs responsive patients, with a dose effect of the G allele. In contrast, no association was found for three other genetic polymorphisms of the CNR1 gene. The G allele of the CNR1 gene polymorphisms could be a psychopharmacogenetic rather than a vulnerability factor regarding schizophrenia and its treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2007.05.005DOI Listing

Publication Analysis

Top Keywords

cnr1 gene
12
1359g/a polymorphism
8
control subjects
8
cnr1
4
gene pharmacogenetic
4
pharmacogenetic factor
4
factor antipsychotics
4
antipsychotics susceptibility
4
gene
4
susceptibility gene
4

Similar Publications

Impacts of maternal separation stress on ethanol intake and endocannabinoid system in adolescent mice.

Neuroscience

November 2024

Molecular and Behavioral Neuroscience Laboratory, Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil. Electronic address:

Clinical and preclinical studies suggest that early life stress can increase the risk of developing ethanol use disorder later in life. Although the endocannabinoid (eCB) system plays a role in stress-related behaviors and ethanol consumption, it remains unclear whether the eCB system is affected in response to a combination of both factors. By using male and female adolescent C57BL/6J mice subjected to a maternal separation (MS) stress paradigm from postnatal day (PND) 1 to 14, we explored (1) the consequences of early life stress experiences on ethanol consumption in adolescent mice and (2) how these events affect the eCB system and neuronal activation in brain regions associated with the reward system.

View Article and Find Full Text PDF

Temporal and spatial layout of endocannabinoid system components in the mouse suprachiasmatic nucleus.

Neuroscience

January 2025

Department of Biological Sciences, Kent State University, 1275 University Esplanade, Kent, OH 44242, USA; School of Biomedical Sciences, Kent State University, 1275 University Esplanade, Kent, OH 44242, USA; Brain Health Research Institute, Kent State University, 1275 University Esplanade, Kent, OH 44242, USA. Electronic address:

Environmental light serves as the main entraining signal for the central circadian pacemaker, the suprachiasmatic nucleus of the hypothalamus (SCN). To shift clock timing with the changing environment, minute adjustments are necessary and the endocannabinoid system (ECS) acts as a neuromodulatory signaling mechanism in the SCN. These systems exert bidirectional effects on one another, still, limited knowledge exists about the role of endocannabinoids in circadian rhythm regulation.

View Article and Find Full Text PDF

The transcription repressor REST in the dorsal root ganglion (DRG) is upregulated by peripheral nerve injury and promotes the development of chronic pain. However, the genes targeted by REST in neuropathic pain development remain unclear. The expression levels of four opioid receptor genes (Oprm1, Oprd1, Oprl1 and Oprk1) and the cannabinoid CB1 receptor (Cnr1) gene in the DRG regulate nociception.

View Article and Find Full Text PDF

Sciatic nerve crush in neonatal rats leads to an extensive death of motor and sensory neurons, serving as a platform to develop new neuroprotective approaches. The endocannabinoid system plays important neuromodulatory roles and has been involved in neurodevelopment and neuroprotection. The present work investigated the role of the cannabinoid receptors CB1 and CB2 in the neuroprotective response after neonatal axotomy.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between dermatoglyphic patterns (fingerprint characteristics) and schizophrenia-spectrum disorders (SSD), suggesting these patterns may reflect neurodevelopmental vulnerabilities.
  • Researchers analyzed the relationship between two genetic polymorphisms in the Cannabinoid Receptor 1 gene and three dermatoglyphic markers among 97 patients with SSD and 112 controls.
  • Findings indicate that one genetic variant, rs2023239, modifies how dermatoglyphic pattern intensity relates to SSD risk, underscoring the potential role of the endocannabinoid system in neurodevelopment and highlighting the need for further research combining genetics and dermatoglyphics.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!